DE678948C - Contrast media for the visualization of the genitourinary system through X-rays - Google Patents
Contrast media for the visualization of the genitourinary system through X-raysInfo
- Publication number
- DE678948C DE678948C DESCH91645D DESC091645D DE678948C DE 678948 C DE678948 C DE 678948C DE SCH91645 D DESCH91645 D DE SCH91645D DE SC091645 D DESC091645 D DE SC091645D DE 678948 C DE678948 C DE 678948C
- Authority
- DE
- Germany
- Prior art keywords
- visualization
- rays
- genitourinary system
- contrast media
- solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
Kontrastmittel für die Sichtbarmachung des Urogenitalsystems durch Röntgenstrahlen Die Röntgendiagnosti k der Krankheiten des Urogenitalsystems hat in den letzten Jahren an Bedeutung gewonnen. Als Kontrastmittel wurden Lösungen anorganischer Jodsalze, z. B. 25 0/0ige Jodlithiumlösungen, verwendet, deren Zuführung auf dem Wege über die Blase mit Hilfe des Katheters erfolgt ist, ein Verfahren, das neben Schmerzhaftigkeit auch noch andere Nachteile aufweist.Contrast media for the visualization of the genitourinary system X-rays The X-ray diagnosis of diseases of the genitourinary system has gained importance in recent years. Solutions were used as contrast media inorganic iodine salts, e.g. B. 25 0/0 iodine lithium solutions are used, their feed a procedure is carried out on the way through the bladder with the help of the catheter, which besides painfulness also has other disadvantages.
Man hat versucht, die Nachteile dieser Methode dadurch zu vermeiden, daß man harnstoffbaltige Natriumjodidlösungen inj izierte. Doch zeigte sich, daß auch bei Verwendung dieses Mittels wie allgemein bei Verwendung anorganischer Jodsalze wenig brauchbare Bilder erhalten werden.Attempts have been made to avoid the disadvantages of this method by that one injected urea-containing sodium iodide solutions. But it turned out that also when using this agent as in general when using inorganic iodine salts few useful images are obtained.
Es ist ferner vorgeschlagen worden, jodierte Pflanzenöle, wie sie in den Präparaten Campiodol, Jodipin, Lipiodol im Handel sind, für die Zwecke der Pyelographie nutzbar zu machen. Aber auch durch keine dieser Verbindungen wurde ein einwandfreier Bilderfolg erzielt. Dazu kommt noch, daß ihre Einverleibung in den Organismus wegen ihrer Wasserunlöslichkeit nur auf retrogradem Wege möglich ist. It has also been suggested to use iodized vegetable oils like them in the preparations Campiodol, Jodipin, Lipiodol are on the market for the purpose of To harness pyelography. But neither was through any of these connections a flawless picture success achieved. In addition, their incorporation into the organism is only possible in a retrograde way because of its insolubility in water is.
Auch andere für die Pyelographie als Röntgenkontrastmittel empfohlene Verbindungen, wie Tetrajodphenolphthalein, a-Monojodhydrin und ß-jodpropionsaures Natrium und andere, kommen wegen ihrer häufig beobachteten toxischen Nebenwirkungen ebenfalls für eine Anwendung nicht in Frage. Others recommended as X-ray contrast media for pyelography Compounds such as tetraiodophenolphthalein, α-monoiodohydrin and ß-iodopropionic acid Sodium, and others, come because of their commonly observed toxic side effects also out of the question for an application.
Es wurde nun gefunden, daßman alle obenerwähnten Nachteile vermeidet und ausgezeichnete kontrastreiche Bilder erzielt, wenn man als Kontrastmittel entweder Lösungen von dibrom-p-acetaininobenzoesauremNatrium oder von 2-oxo-5-jodpyridin-N-essigsaurem Natrium verwendet. It has now been found that all of the disadvantages mentioned above are avoided and excellent high contrast images are obtained when used as a contrast agent either Solutions of sodium dibromo-p-acetaininobenzoic acid or of 2-oxo-5-iodopyridine-N-acetic acid Sodium used.
Verbindungen dieser Art besitzen auf Grund ihrer physiologischen Indifferenz, ihrer großen Wasserlöslichkeit und ihrer Stabilität den besonideren Vorteil, daß sie intravenös in hoher Konzentration dem Körper einverleibt werden können, wobei sich - Bilder ganz hervorragender Qualität erzielen lassen. Compounds of this type have due to their physiological Indifference, their great water solubility and their stability the more special Advantage that they are incorporated into the body intravenously in high concentrations can, whereby - images of very excellent quality can be achieved.
Verwendet man beispielsweise 40 0/0ige Lösungen ~ von 2-oxo-5-jodpyridin-N-essigsaurem Natrium oder 50 obige Lösungen von dibrom-p-acetaminobenzoesaurem Natrium, so läßt sich bereits kurze Zeit nach der Einverleibung das Urogenitalsystem in ausgezeichneten Klarheit auf dem Röntgenschirm darstellen und photographieren. If, for example, 40% solutions of 2-oxo-5-iodopyridine-N-acetic acid are used Sodium or the above solutions of sodium dibromo-p-acetaminobenzoate, so leave The genitourinary system is already in excellent shape just a short time after it has been incorporated Show clarity on the X-ray screen and take photos.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESCH91645D DE678948C (en) | 1929-09-26 | 1929-09-26 | Contrast media for the visualization of the genitourinary system through X-rays |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESCH91645D DE678948C (en) | 1929-09-26 | 1929-09-26 | Contrast media for the visualization of the genitourinary system through X-rays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE678948C true DE678948C (en) | 1939-07-25 |
Family
ID=7444699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DESCH91645D Expired DE678948C (en) | 1929-09-26 | 1929-09-26 | Contrast media for the visualization of the genitourinary system through X-rays |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE678948C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE973275C (en) * | 1951-12-01 | 1960-01-07 | F J Collin A G | Device for regulating the flow rate of nozzles for open ovens with gas heating or for gas generation, in particular coke ovens |
-
1929
- 1929-09-26 DE DESCH91645D patent/DE678948C/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE973275C (en) * | 1951-12-01 | 1960-01-07 | F J Collin A G | Device for regulating the flow rate of nozzles for open ovens with gas heating or for gas generation, in particular coke ovens |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE678948C (en) | Contrast media for the visualization of the genitourinary system through X-rays | |
| DE1518440C3 (en) | Process for the preparation of a salt of a sulfomethyl derivative of polymyxin B or E. | |
| AT129942B (en) | Contrast media for fluoroscopy. | |
| DE2556001C3 (en) | Injectable ready-to-use solutions containing alkali anrenoate | |
| DE1932231A1 (en) | Diagnostic and therapeutic preparation based on a chelate-bound radio-nuclide | |
| DE19627309C2 (en) | Aqueous injectable formulations usable as contrast agents | |
| DE646116C (en) | Contrast media for the roentgenological visualization of hollow systems of the body | |
| DE806701C (en) | Contrast media for the roentgenographic representation of body cavities and processes for their production | |
| DE1792448C3 (en) | Process for the preparation of stable solutions of therapeutically applicable benzodiazepine derivatives which are suitable for parenteral administration | |
| DE519320C (en) | Process for the production of sulphobasic mercury compounds | |
| DE919908C (en) | X-ray contrast media for bronchography and hysterosalpingography | |
| DE1234931B (en) | X-ray contrast media | |
| DE695235C (en) | Iodine-containing, organic, orally usable contrast medium is suitable for visualizing the kidney and urinary tract using X-rays | |
| DE1207048B (en) | X-ray contrast media and process for their preparation | |
| DE735441C (en) | X-ray contrast media | |
| DE2309263C2 (en) | Infusion concentrate containing 5,5-diphenylhydantoin sodium | |
| DE1814671C3 (en) | Radioactive di (fluoresceinyl) mercury derivatives | |
| DE711488C (en) | Process for the production of a disinfectant | |
| DE629841C (en) | Process for the preparation of an aqueous quinine solution for injection purposes | |
| AT129934B (en) | Process for the preparation of quinine solutions. | |
| AT218175B (en) | X-ray contrast medium to visualize the biliary tract | |
| AT249263B (en) | X-ray contrast media | |
| AT107592B (en) | Process for the preparation of an agent suitable for subcutaneous and intravenous injections. | |
| AT129598B (en) | Process for the production of solutions of basic quinine which can be used in therapy. | |
| DE504183C (en) | Process for the preparation of therapeutically valuable, sterile and durable solutions of p-dialkylaminoarylphosphinous acid salts suitable for injections |